Explore the State of the European Medical Cannabis Industry at Cannabis Europa 2019
After a year of rapid change, leaders will gather in London to discuss what lies ahead for the medical cannabis industry in Europe
- Europe's most important medical cannabis conference, Cannabis Europa, takes place at London's Southbank Centre on June 24th and 25th
- Cannabis Europa 2018 was a central platform for those who brought about change to the UK's cannabis laws
- European nations including the UK, France and Luxembourg have taken steps toward changing their medical cannabis laws this past year, but social barriers are impeding growth
- Major foreign investors are confident in a bright future for European medical cannabis
13 Jun, 2019, 07:34 ET
LONDON, June 13, 2019 /PRNewswire/ -- 2019 has been an historic year for medical cannabis in Europe, as major countries including the UK, France and Luxembourg have changed or began reviewing their stance on its therapeutic use. One year after the inaugural Cannabis Europa London - an event seen as a major catalyst for change - politicians, medical experts, investors, industry heavyweights and patients will reconvene to analyse the year gone by and shape the future of the industry.
However, despite legal and political change, many systems ingrained in European culture and society are blocking the growth of the industry. Simple obstacles such as national media outlets' firewalls blocking the word "cannabis", social media bans on advertising, or business owners' hesitancy to promote their stock of legal CBD products for fear of prejudice show that society at large is not yet in step with the times. This has a direct impact on patient access to medication.
A Glimpse Into The Future
As the UK begins importing shipments of medical cannabis and France begins taking steps down the same path, the question on everyone's lips is, what is next and how can we overcome the challenges facing the industry?
Our speakers will answer these questions and more. Highlights from this year's lineup of speakers will include:
- Cam Battley, CCO of Aurora
- Andrew Neil, Broadcaster and Journalist
- Norman Lamb MP, UK House of Commons
- Dr Marcos Van Velde, Head of the Dutch Office of Medicinal Cannabis
- Emily Paxhia, Partner at Poseidon Asset Management
- George Kruis, England International Rugby Player
- Hannah Deacon, Campaigner and Carer
For the full list of speakers, please visit: www.cannabis-europa.com/speakers
Co-Founder and Managing Director of Cannabis Europa Alastair Moore said, "our team has worked incredibly hard to bring together some of the world's most influential voices in the medical cannabis space, for an event which is shaping up to be as impactful as the last. Although we are steadily improving patient access to medication, there are still many questions to be asked and problems to be solved and it is here, at Cannabis Europa, that these conversations will happen."
Canadian cannabis specialists Supreme, who have recently come on board as a gold partner for Cannabis Europa, are looking at expanding their European activities. Navdeep Dhaliwal, CEO of Supreme Cannabis said, "Thank you to Cannabis Europa for bringing together the medical cannabis community to discuss what lies ahead for the industry in Europe. Europe is on the frontier and we are excited for it to be one of the largest markets in the world. Through our partnership with Malta Enterprises and Medigrow Lesotho, we welcome the opportunity to bring our expertise in production and operations from Canada's highly regulated market."
Patient Access and Medical Breakthroughs
In the UK, stories of parents going to great lengths to legally obtain medication for their children dominated headlines in 2018, bringing the issue into the public eye and ultimately leading to changes in legislation. While these stories may have slipped from the front pages, many people still struggle to obtain this life-changing medication. Improving patient access to medical cannabis, and the practical logistics of how to go about this, will be one of the core issues discussed at Cannabis Europa.
Charlotte Caldwell will be speaking at the event, sharing her own personal story of her fight for access for medical cannabis for her son Billy, as will Hannah Deacon, mother of Alfie Dingley, and leading patient advocacy groups such as the UK's MS Society.
Dr. Axel Gille, Managing Director of headline sponsor Aurora Europe said, "Awareness of cannabis as medicine is growing throughout Europe, a market with about 600 million people, which includes millions of Europeans currently struggling with conditions that are commonly and effectively treated with cannabis in North America. Aurora is working with government partners across Europe to expand access to medical cannabis, and has seen great success. We are now the largest authorised importer, exporter, and distributor of EU-GMP certified medical cannabis in the European Union, and look forward to continuing to enhance patient access across Europe."
For more information, please visit www.cannabis-europa.com.
About Cannabis Europa
The foremost arena to share knowledge and shape the future of medical cannabis in Europe.
Cannabis Europa is Europe's leading medical cannabis conference series with events across the continent. It is a thought leadership platform and an opportunity to connect with influential leaders in science, policy and business. Our team is focused on bringing groundbreaking and high-quality content, speakers and experiences to audiences in Europe and internationally.
SOURCE Cannabis Europa
Share this article